PET imaging with [18F]3′-deoxy-3′-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer

被引:0
|
作者
Hinrich A. Wieder
Hans Geinitz
Robert Rosenberg
Florian Lordick
Karen Becker
Alexander Stahl
Ernst Rummeny
Jörg R. Siewert
Markus Schwaiger
Jens Stollfuss
机构
[1] Technische Universität München,Department of Nuclear Medicine
[2] Technische Universität München,Department of Radiology
[3] Technische Universität München,Department of Radiotherapy
[4] Technische Universität München,Department of Surgery
[5] Technische Universität München,Department of Medicine III
[6] Technische Universität München,Department of Pathology
关键词
Rectal cancer; Therapy monitoring; FLT-PET; Proliferation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:878 / 883
页数:5
相关论文
共 50 条
  • [41] Comparison of 3′-deoxy-3′-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma
    Jeong, Su Young
    Lim, Sang Moo
    NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (07) : 977 - 981
  • [42] Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3′-Deoxy-3′-[18F]Fluorothymidine in Preclinical Models of Lung Cancer
    Schelhaas, Sonja
    Held, Annelena
    Wachsmuth, Lydia
    Hermann, Sven
    Honess, Davina J.
    Heinzmann, Kathrin
    Smith, Donna-Michelle
    Griffiths, John R.
    Faber, Cornelius
    Jacobs, Andreas H.
    CANCER RESEARCH, 2016, 76 (24) : 7096 - 7105
  • [43] 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma
    Benz, Matthias R.
    Czernin, Johannes
    Allen-Auerbach, Martin S.
    Dry, Sarah M.
    Sutthiruangwong, Piriya
    Spick, Claudio
    Radu, Caius
    Weber, Wolfgang A.
    Tap, William D.
    Eilber, Fritz C.
    CANCER, 2012, 118 (12) : 3135 - 3144
  • [44] Prospective comparison of 18F-FDG and 3′-deoxy-3′-[18F]fluorothymidine PET/CT in the differentiation and characterization of periampullary tumors
    Cheng, M.
    Wang, H.
    Liu, K.
    Yen, R.
    Tzen, K.
    Wu, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S582 - S582
  • [45] 3′-deoxy-3′-[18F]fluorothymidine and 2-[18F]fluoro2-deoxy-D-glucose as markers of response to cisplatin therapy in vivo
    Leyton, J
    Perumal, M
    Dhaliwal, H
    Litago, J
    Aboagye, E
    BRITISH JOURNAL OF CANCER, 2004, 91 : S45 - S45
  • [46] Bone metastasis of a breast cancer detected by 3′-deoxy-3′-18F-fluorothymidine PET/CT
    Cochet, A.
    Berriolo-Riedinger, A.
    Girault, S.
    Rousseau, C.
    Brunotte, F.
    Couturier, O.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2009, 48 (05): : N45 - N46
  • [47] [18F]3′deoxy-3′-flurothymidine (FLT) for PET imaging DNA synthesis in glioma patients.
    Spence, AM
    Muzi, M
    Grierson, J
    Swanson, K
    Link, J
    Mankoff, DA
    O'Sullivan, F
    Krohn, KA
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9130S - 9130S
  • [48] Monitoring early response to taxane therapy in advanced breast cancer with circulating tumor cells and [18F] 3′-deoxy-3′-fluorothymidine PET: a pilot study
    Contractor, Kaiyumars
    Aboagye, Eric O.
    Jacob, Jimmy
    Challapalli, Amarnath
    Coombes, R. Charles
    Stebbing, Justin
    BIOMARKERS IN MEDICINE, 2012, 6 (02) : 231 - 233
  • [49] Improved elution procedure of 3′-Deoxy-3′-[18F]fluorothymidine [18F]FLT for safer human injectable radiotracer
    Nakka, Surendra
    Al Qahtani, Mohammed H.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2015, 58 : S387 - S387
  • [50] Positron Emission Tomography with [18F]-3′-Deoxy-3′fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: a Pilot Study
    Farrokh Dehdashti
    Perry W. Grigsby
    Robert J. Myerson
    ILKe Nalbantoglu
    Changqing Ma
    Barry A. Siegel
    Molecular Imaging and Biology, 2013, 15 : 106 - 113